SOUTH PLAINFIELD, N.J., Nov. 18, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of a no-cost testing program for aromatic L-amino acid decarboxylase (AADC) ...
SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals ...
SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals ...
SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who ...
BALTIMORE--(BUSINESS WIRE)--Following a competitive procurement process, Professional Testing Corporation ® (PTC) has selected Prometric ® as their partner for the global administration of PTC client ...
SOUTH PLAINFIELD, N.J., April 14, 2021-- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who have ...
SOUTH PLAINFIELD, N.J., April 14, 2021 -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who have ...
Following a competitive procurement process, Professional Testing Corporation ® (PTC) has selected Prometric ® as their partner for the global administration of PTC client programs. Under the terms of ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する
フィードバック